According to previous studies, AD patients are known to have increased levels of chemokines (such as IL-8, CCL17, and CXCL10) and cytokines (such as IL-4, IL-6, and IL-13), compared to healthy individuals (Yamanaka and Mizutani, 2011). This evidence concerns the gene CCL17 and Alzheimer disease.